Cerebrospinal fluid CXCL13 in multiple sclerosis: a suggestive prognostic marker for the disease course

Publikation: Bidrag til tidsskriftTidsskriftartikelfagfællebedømt

  • Mohsen Khademi
  • Ingrid Kockum
  • Magnus L Andersson
  • Ellen Iacobaeus
  • Lou Brundin
  • Sellebjerg, Finn Thorup
  • Jan Hillert
  • Fredrik Piehl
  • Tomas Olsson
Levels of CXCL13, a potent B-cell chemoattractant, are elevated in the cerebrospinal fluid (CSF) during multiple sclerosis (MS) and are associated with markers of MS activity. Levels decrease upon effective treatments.
OriginalsprogEngelsk
TidsskriftMultiple Sclerosis
Vol/bind17
Udgave nummer3
Sider (fra-til)335-43
Antal sider9
ISSN1352-4585
DOI
StatusUdgivet - 2011

ID: 40194240